Effects of MDR1 Gene Polymorphism on Efficacy and Hematotoxicity of Epirubicin-Based Regimen in Patients with Breast Cancer in Southwest China

Effects of MDR1 Gene Polymorphism on Efficacy and Hematotoxicity of Epirubicin-Based Regimen in Patients with Breast Cancer in Southwest China

Review Data

Q: Is the topic relevant to the journal area of interest? Is it contemporary and interesting for

researchers?

A: Very good

 

Abstract & Keywords

Q: Are all required components included in the abstract? Are the keywords appropriately chosen?

A: Very good

 

Goal

Q: Is the goal explicitly stated in the Introduction? Is its formulation clear and unambiguous?

A: Good

 

Structure

Q: Is the paper's structure coherent? Is it in coherence with the goal of the paper?

A: Good

 

Comments:

A few minor errors have been noted in the manuscript:

  • In Materials and Methods, the word “forward” has been misspelt under the subheading “The primer design of MDR1 gene SNP” throughout.
  • In the 2nd sentence under “Statistical Analysis”, “clinical basic characteristics” should be reframed as “basic clinical characteristics”.
  • In the 10th sentence of first paragraph of Discussion, the words “affects” and “attribute” should be changed to “affect” and “attributed” respectively.

·       The heading “Conclussion” should be corrected to “Conclusion”.

 

Tools and Methods

Q: Are methods the author uses adequate and well used?

A: Very good

 

Discussion & Conclusion

Q: Is it related to the results presented before? Do you consider them as coherent?

A: Very good

 

Comments:

The Results are clearly explained and aptly supported by data. The study is well-executed, and the Conclusion provides an apt summary of the findings of the present study. It suggests that C3435T polymorphism may be a risk factor for grade III ~ IV leukopenia in breast cancer patients treated with Epirubicin regimen in Southwest China. Confirmation of the results are further required by large sample, multicenter clinical studies.

 

Literature

Q: Does the author utilize relevant literature?

A: Very good

 

Author's knowledge

Q: What is the level of the author’s knowledge? Does the author utilize all recent contributions relevant to the topic?

A: Good

 

Length

Q: Is the length of the paper adequate to the significance of the topic? Do you suggest shortening the paper without losing its value?

A: Good

 

Figures & Tables

Q: Does the author use them suitably? Are legend and notations clear?

A: Excellent

 

Writing style

Q: Is it clear and understandable?

A: Good

 

Further comments on the paper

Comments: The study investigates the predictive value of multi-drug resistance gene (MDR1) polymorphism in the efficacy and hematological toxicity of chemotherapy regimen based on Epirubicin in patients with breast cancer in Southwest China. The fact that the incidence of breast cancer is ranked first place as a deadly disease among female cancer patients, makes the study significant. It includes patients who have received Epirubicin-based chemotherapy, and polymorphism of C1236T, G2677T/A and C3435T were detected by time-of-flight mass spectrometry (TOF-MS).

 

Q: Would you recommend this manuscript for further publication?

A: Yes - Suitable to be published

If you have any questions and clarifications you can write to the journal.

Thanks,
Science Repository Team

 
 

Author Info

Corresponding Author
Yilan Huang
Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, China

Article Info

Article Type
Research Article
Publication history
Received: Mon 15, Mar 2021
Accepted: Fri 19, Mar 2021
Published: Tue 30, Mar 2021
Copyright
© 2023 Yilan Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.COR.2021.04.04